作者：
Natrajan,R. [1]
;
Mackay,A. [2]
;
Lambros,M.B. [3]
;
Weigelt,B. [4]
;
Wilkerson,P.M. [5]
;
Manie,E. [6]
;
Grigoriadis,A. [7]
;
A'Hern,R. [8]
;
VanDerGroep,P. [9]
;
Kozarewa,I. [10]
;
Popova,T. [11]
;
Mariani,O. [12]
;
Turajlic,S. [13]
;
Furney,S.J. [14]
;
Marais,R. ;
Rodruigues,D.-N. ;
Flora,A.C. ;
Wai,P. ;
Pawar,V. ;
McDade,S. ;
Carroll,J. ;
Stoppa-Lyonnet,D. ;
Green,A.R. ;
Ellis,I.O. ;
Swanton,C. ;
VanDiest,P. ;
Delattre,O. ;
Lord,C.J. ;
Foulkes,W.D. ;
Vincent-Salomon,A. ;
Ashworth,A. ;
Stern,M.H. ;
Reis-Filho,J.S.
作者单位：
Cancer Research UK Clinical Trials Unit, Institute of Cancer Research, Sutton, SM2 5 NG, United
[1]
University Medical Centre Utrecht, 3584 CX Utrecht, Netherlands
[2]
Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal
[3]
Breakthrough Research Unit, Bermondsey Wing, Guy's Hospital, London, SE1 9RT, United Kingdom
[4]
Nuclear Receptor Transcription Laboratory, Cancer Research UK Cambridge Research Institute
[5]
Signal Transduction Laboratory, Cancer Research UK London Research Institute, London, WC2A 3LY
[6]
Centre for Cancer Research and Cell Biology, Queen's University, Belfast, BT9 7BL, United Kingdom
[7]
Translational Cancer Therapeutics Laboratory, Cancer Research UK London Research Institute, London
[8]
Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, United
[9]
Institut Curie, INSERM U830, 75248 Paris, France, Institut Curie, Department of Tumour Biology
[10]
Signal Transduction Team, Division of Cell and Molecular Biology, Institute of Cancer Research
[11]
Institut Curie, Department of Tumour Biology, 75248 Paris, France
[12]
Department of Histopathology, School of Molecular Medical Sciences, University of Nottingham and
[13]
Institut Curie, INSERM U830, 75248 Paris, France
[14]
发布时间
2013-11-20
换一批
换一批
